共 198 条
[1]
Teschendorf D(2009)What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases? Mol Neurodegener 4 38-50
[2]
Link CD(2012)Different 8-hydroxyquinolines protect models of TDP-43 protein, alpha-synuclein, and polyglutamine proteotoxicity through distinct mechanisms J Biol Chem 287 4107-4120
[3]
Tardiff DF(2008)Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta Neuron 59 43-55
[4]
Tucci ML(2008)Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial Lancet Neurol 7 779-786
[5]
Caldwell KA(2011)The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity J Neurochem 119 220-230
[6]
Caldwell GA(1985)Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc Natl Acad Sci USA 82 4245-4249
[7]
Lindquist S(1993)Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide Cell 75 1039-1042
[8]
Adlard PA(1992)Alzheimer's disease: the amyloid cascade hypothesis Science 256 184-185
[9]
Cherny RA(2009)The Caenorhabditis elegans Aß1-42 model of Alzheimer disease predominantly expresses Aß3-42 J Biol Chem 284 22697-22702
[10]
Finkelstein DI(1995)Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans Proc Natl Acad Sci USA 92 9368-9372